Key takeaways
- Top pick: Neuralink, best for: People with paralysis joining implant trials, and the researchers running them. Neuralink runs implant trials in the US, Canada, the UK and the UAE, with seven patients in the UK's GB-PRIME study, according to University College London Hospitals.
- Also near the top: Synchron, best for: Patients with severe paralysis seeking a less invasive implant; and Precision Neuroscience, best for: Hospitals mapping brain activity during surgery.
- How it was ranked: 10 deep tech companies compared. Each verdict is below.
Best Brain-Computer Interface Companies: Top 10 Ranked. Neuralink ranks first, with a Lister Score of 97.4.
Neuralink leads for fully implanted, high-channel BCIs, and
Synchron is the most proven route that avoids open brain surgery.
Precision Neuroscience has the first FDA clearance for a next-generation cortical interface, while
Emotiv is the most established choice for non-invasive EEG headsets used in research and development.
Best Brain-Computer Interface Companies in 2026, compared| RANK | ENTRY | BEST FOR | SCORE | FROM |
|---|
| 1 |  NeuralinkNeuralink runs implant trials in the US, Canada, the UK and the UAE, with seven patients in the UK's GB-PRIME study, according to University College London Hospitals. | People with paralysis joining implant trials, and the researchers running them | 97.4 | Not public |
|---|
|
| 2 |  SynchronSynchron's $200 million Series D was led by Double Point Ventures, with ARCH Ventures, Khosla Ventures and Bezos Expeditions among existing investors. | Patients with severe paralysis seeking a less invasive implant | 96.1 | Not public |
|---|
|
| 3 |  Precision NeurosciencePrecision received FDA 510(k) clearance for the Layer 7 Cortical Interface in April 2025, for implantation of up to 30 days. | Hospitals mapping brain activity during surgery | 94.8 | Custom |
|---|
|
| 4 |  Blackrock NeurotechTether said in April 2024 that Blackrock's technology had been used by more than 40 people. | Academic and clinical teams running implanted BCI research | 93.4 | Custom |
|---|
|
| 5 |  ParadromicsParadromics reported in September 2026 that its first Connect-One participant was holding real-time conversations using Connexus. | People who have lost speech through motor neuron disease or paralysis | 92.1 | Not public |
|---|
|
| 6 |  Science CorpScience reports that 84% of PRIMA trial participants regained the ability to read letters, numbers and words at 12 months. | Eye clinics treating geographic atrophy in Europe | 90.8 | Not public |
|---|
|
| 7 |  EmotivEmotiv prices its 5-channel Insight EEG headset at $499. | Researchers and developers building non-invasive BCIs | 89.5 | From $499 |
|---|
|
| 8 |  NeurableNeurable lists its Neurable One headphones, which carry 12 EEG sensors, at $499. | Knowledge workers who want to track focus without a headset | 88.2 | $499 |
|---|
|
| 9 |  g.tec medical engineeringg.tec says its recoveriX treatment is offered in 14 countries. | Research labs and rehabilitation clinics | 86.9 | Custom |
|---|
|
| 10 |  ONWARD MedicalONWARD said in January 2026 that seven people had received its investigational ARC-BCI therapy. | People with spinal cord injury in clinical studies | 85.5 | Not public |
|---|
|
|
How to choose
Start from what you need it for. Where each entry fits best:
- Neuralink (#1): People with paralysis joining implant trials, and the researchers running them
- Synchron (#2): Patients with severe paralysis seeking a less invasive implant
- Precision Neuroscience (#3): Hospitals mapping brain activity during surgery
- Blackrock Neurotech (#4): Academic and clinical teams running implanted BCI research
- Paradromics (#5): People who have lost speech through motor neuron disease or paralysis
- Science Corp (#6): Eye clinics treating geographic atrophy in Europe
- Emotiv (#7): Researchers and developers building non-invasive BCIs
- Neurable (#8): Knowledge workers who want to track focus without a headset
- g.tec medical engineering (#9): Research labs and rehabilitation clinics
- ONWARD Medical (#10): People with spinal cord injury in clinical studies
Each entry's full verdict is below.
The ranking, in detail
01
Fully implanted, wireless high-channel brain implant
Neuralink, based in Fremont, California, makes the N1 implant, a wireless device whose ultra-thin threads are placed by a surgical robot, letting people with paralysis control computers with their thoughts in clinical trials. It has raised a $650 million Series E.
PROS- Best-funded and most visible BCI programme
- Fully implanted and wireless
CONS- Investigational, not approved for sale
- Requires brain surgery
- Best for
- People with paralysis joining implant trials, and the researchers running them
- Where it falls short
- It requires brain surgery to implant the device.
- Pick something else if
- you want a non-invasive solution.
97.4
02
Stentrode BCI implanted through a blood vessel
Synchron, based in New York, makes the Stentrode, a BCI delivered through the jugular vein to sit in a blood vessel over the motor cortex, avoiding open brain surgery. It raised a $200 million Series D in 2025 to prepare a pivotal trial and commercial launch.
PROS- No open brain surgery needed
- Moving toward a pivotal trial
CONS- Fewer electrodes than surface or penetrating arrays
- Not yet approved for sale
- Best for
- Patients with severe paralysis seeking a less invasive implant
- Where it falls short
- It is not yet approved for sale.
- Pick something else if
- you need a commercially available device today.
96.1
03
Thin-film cortical interface on the brain's surface
Precision Neuroscience, based in New York, makes the Layer 7 Cortical Interface, a flexible film with 1,024 electrodes that sits on the surface of the brain without penetrating tissue, and has tested it in more than 35 patients with hospital partners.
PROS- FDA-cleared device in clinical use
- Does not penetrate brain tissue
CONS- Clearance limited to 30-day use
- Permanent implant still in development
- Best for
- Hospitals mapping brain activity during surgery
- Where it falls short
- It is limited to short-term use and lacks a permanent implant option.
- Pick something else if
- you need long-term or permanent brain monitoring.
94.8
04
Utah Array implants for research and patients
Blackrock Neurotech, based in Salt Lake City, makes the Utah Array, an implantable microelectrode array used in human brain implants since 2004 that underpins much of the BCI research done in people. Tether took a majority stake with a $200 million investment in April 2024.
PROS- Longest human track record in implanted BCIs
- Research hardware used by many labs
CONS- Many systems still use a wired skull connector
- No commercial approval for home use yet
- Best for
- Academic and clinical teams running implanted BCI research
- Where it falls short
- Many systems still use a wired skull connector.
- Pick something else if
- you need wireless implants.
93.4
05
High-data-rate Connexus implant for speech
Paradromics, based in Austin, Texas, makes the Connexus BCI, with 421 microelectrodes that record individual neurons and a transceiver implanted in the chest. The first implant in its FDA-approved Connect-One study took place at University of Michigan Health in 2026.
PROS- Records from individual neurons
- Early real-time speech results
CONS- Very early clinical stage
- Requires brain surgery
- Best for
- People who have lost speech through motor neuron disease or paralysis
- Where it falls short
- The technology requires invasive brain surgery to function.
- Pick something else if
- you want a non-invasive solution.
92.1
06
PRIMA retinal implant that restores some sight
Science Corp, based in Alameda, California, sells PRIMA, a 2 mm wireless retinal implant used with camera glasses to restore central vision to people with geographic atrophy from age-related macular degeneration. It announced its European commercial launch in July 2026 after CE marking.
PROS- CE marked and launching commercially in Europe
- Strong clinical trial results
CONS- Restored vision is low resolution
- Not approved in the US
- Best for
- Eye clinics treating geographic atrophy in Europe
- Where it falls short
- It is not approved in the US.
- Pick something else if
- you live in the United States.
90.8
07
EEG headsets for research and BCI development
Emotiv, based in San Francisco, sells EEG headsets such as Insight, EPOC X and Flex for brain research, neuromarketing and BCI development, with software for recording and analysing brain data.
PROS- Affordable, widely used research headsets
- Mature recording and analysis software
CONS- Lower signal quality than implants or clinical EEG
- Some software features need a subscription
- Best for
- Researchers and developers building non-invasive BCIs
- Where it falls short
- Signal quality is lower than implants or clinical EEG.
- Pick something else if
- you need implant-level signal accuracy.
89.5
08
EEG headphones that track focus
Neurable, a University of Michigan spinout, builds EEG sensors into everyday headphones, including its own Neurable One and the MW75 Neuro made with Master & Dynamic, to track focus and fatigue.
PROS- Familiar headphone form factor
- No gel or setup needed
CONS- Wellness product, not a medical device
- Fewer channels than research EEG
- Best for
- Knowledge workers who want to track focus without a headset
- Where it falls short
- It is a wellness product, not a medical device.
- Pick something else if
- you need clinical-grade diagnostics.
88.2
09
BCI systems and recoveriX stroke rehabilitation
g.tec medical engineering, based in Schiedlberg, Austria, has built invasive and non-invasive BCI recording systems since 1999 and runs recoveriX, a BCI-based therapy for people recovering from stroke and multiple sclerosis.
PROS- Long track record in research BCIs
- Clinical rehabilitation product in use
CONS- Sold mainly to labs and clinics
- Less known outside research circles
- Best for
- Research labs and rehabilitation clinics
- Where it falls short
- It is less known outside research circles.
- Pick something else if
- you need a widely recognized brand.
86.9
10
ARC-BCI pairing a brain implant with spinal stimulation
ONWARD Medical, based in Eindhoven, Netherlands, and listed on Euronext, develops ARC-BCI, which pairs CEA-Clinatec's WIMAGINE brain implant with its implanted spinal cord stimulator to restore thought-driven movement after spinal cord injury.
PROS- Restores movement, not just computer control
- FDA Breakthrough Device Designation
CONS- Investigational, small number of implants
- Two implanted systems required
- Best for
- People with spinal cord injury in clinical studies
- Where it falls short
- Investigational, small number of implants.
- Pick something else if
- you need a single-implant solution.
85.5
Put your company on this ranking
Ask us for a quote for one, two or three years. Nothing recurring.
Positions #4 to #10 are available on request. Contact us.
Not on this ranking?Tell us about your company and we will reply by email.
Frequently asked questions
What are the best Brain-Computer Interface Companies?
Neuralink ranks first on Lister. Neuralink, based in Fremont, California, makes the N1 implant, a wireless device whose ultra-thin threads are placed by a surgical robot, letting people with paralysis control computers with their thoughts in clinical trials. It has raised a $650 million Series E.
What are the top 10 Brain-Computer Interface Companies?
1. Neuralink; 2. Synchron; 3. Precision Neuroscience; 4. Blackrock Neurotech; 5. Paradromics; 6. Science Corp; 7. Emotiv; 8. Neurable; 9. g.tec medical engineering; 10. ONWARD Medical.
Some links on Lister are affiliate links. Rankings are not affected.
Related rankings
